Biolinerx Ltd., of Tel Aviv, Israel, said it closed its public offering of 28 million American depositary shares priced at 75 cents apiece for gross proceeds of $15.4 million. Net proceeds will be used for general corporate purposes. Oppenheimer & Co. Inc. acted as sole book-running manager, while Maxim Group LLC acted as co-manager.